MIACALCIN
Novartis Ag
| Research |
OneLook
Acronym Finder
|
| Serial Number | 74255027 |
| Registration Number | 1726984 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | G30 |
| Employee Name | HAMILTON, MICHAEL |
Timeline
| 1984-06-29 | Date of First Use |
| 1992-03-13 | Application Filed |
| 1992-08-04 | Published for Opposition |
| 1992-10-27 | Trademark Registered |
| 2012-10-27 | Renewal Date |
| 2012-12-07 | Location: GENERIC WEB UPDATE |
| 2012-12-07 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  NOVARTIS AG |
| Name Change Details | NC41000001BY CHANGE OF NAME |
| Address | CH 4002 BASLE CH-4002 BASLE CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 018 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceuticals used for the treatment of Paget's disease, osteoporosis and hypercalcemia |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1992-05-14 | 1 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 1992-07-02 | 2 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1992-08-04 | 3 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 1992-10-27 | 4 R.PR A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 1998-10-27 | 5 815F I:Incoming Correspondence |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 1999-03-12 | 6 C15A O:Outgoing Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2002-11-26 | 7 E89R I:Incoming Correspondence |
| REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | 2002-11-26 | 8 89AF I:Incoming Correspondence |
| REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | 2002-11-26 | 9 89AF I:Incoming Correspondence |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2003-03-09 | 10 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2003-03-09 | 11 RNL1 Q: |
| PAPER RECEIVED | 2004-12-17 | 12 MAIL I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-12-28 | 13 TCCA I:Incoming Correspondence |
| CASE FILE IN TICRS | 2008-03-13 | 14 CFIT O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-17 | 15 TCCA I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2010-03-02 | 16 APRE A:Allowance for Publication |
| REVIEW OF CORRESPONDENCE COMPLETE | 2010-03-03 | 17 CORV P: |
| TEAS SECTION 8 & 9 RECEIVED | 2012-11-12 | 18 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-12-07 | 19 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2012-12-07 | 20 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | 2012-12-07 | 21 RNL2 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2012-12-07 | 22 NA89 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-10-27 | 23 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2022-01-10 | 24 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-05-10 | 25 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-05-10 | 26 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) | 2022-05-10 | 27 RNL3 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-05-10 | 28 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MIACALCIN 74255027 1726984 Live/Registered |
NOVARTIS AG 1992-03-13 |
 MIACALCIN 73495876 1362853 Dead/Cancelled |
SANDOZ, INC., 1984-08-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 